RENASANT CORP
RNSTOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | $181.3M | $195.5M | $144.7M | $166.1M | $175.9M | $83.7M |
| Total assets | $26.75B | $18.03B | $17.36B | $16.99B | $16.81B | $14.93B |
| Total liabilities | $22.87B | $15.36B | $15.06B | $14.85B | $14.60B | $12.80B |
| Equity | $3.88B | $2.68B | $2.30B | $2.14B | $2.21B | $2.13B |
| EPS (diluted) | $2.07 | $3.27 | $2.56 | $2.95 | $3.12 | $1.48 |
| Shares out. | 63.7M | 56.2M | 56.0M | 55.8M | 56.2M | 56.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 4.7%
- Return on assets
- 0.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 85.5%
- Debt / equity
- 5.89×
- Book value / share
- $61.03
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −7.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −0.3%clean
- Piotroski F-Score
- 3/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 2 good- High leverage (liabilities > 70% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- State Street CorpPassive (13G)May 12, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Victory Capital Management IncPassive (13G)Aug 8, 2025
- Dimensional Fund Advisors LpPassive (13G)Jul 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Dale Albert J IiiDirector | May 19, 2026 | Sell | 1,650 | $39.80 |
| Mcgraw Edward RobinsonDirector | May 15, 2026 | Option exercise | 1,040 | $39.82 |
| Waycaster C MitchellOfficer — Executive Vice Chairman | May 14, 2026 | Sell | 12,704 | $39.50 |
| Creekmore JohnDirector | Apr 28, 2026 | Grant | 2,060 | $0.00 |
| Mcgraw Edward RobinsonDirector | Apr 28, 2026 | Grant | 2,060 | $0.00 |
| Suggs Sean M.Director | Apr 28, 2026 | Grant | 2,060 | $0.00 |
| Parker Ted EDirector | Apr 28, 2026 | Grant | 2,060 | $0.00 |
| Moore Diana ReneeDirector | Apr 28, 2026 | Grant | 2,060 | $0.00 |
| Holland Neal A JrDirector | Apr 28, 2026 | Grant | 2,060 | $0.00 |
| Levy Jonathan ADirector | Apr 28, 2026 | Grant | 2,060 | $0.00 |
| Flenorl Rose J.Director | Apr 28, 2026 | Grant | 2,060 | $0.00 |
| Foy JohnDirector | Apr 28, 2026 | Grant | 2,060 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.9M | 7.3 | +5.2% |
| Apr 30, 2026 | 4.6M | 7.0 | +9.0% |
| Apr 15, 2026 | 4.2M | 6.5 | +13.8% |
| Mar 31, 2026 | 3.7M | 5.2 | -6.4% |
| Mar 13, 2026 | 4.0M | 5.0 | -1.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 15, 2026
- Entered a material agreement · New financial obligation · Regulation FD disclosureMay 7, 2026
- Amended charter or bylaws · Shareholder voteMay 1, 2026
- Regulation FD disclosureApr 30, 2026
- Results of operations · Regulation FD disclosureApr 28, 2026
- Director / officer changeMar 16, 2026
- Regulation FD disclosureFeb 3, 2026
- Results of operations · Regulation FD disclosureJan 27, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (8)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.